ID
45646
Beskrivning
Principal Investigator: Neal Freedman, PhD, MPH, National Cancer Institute, Rockville, MD, USA MeSH: Neoplasms https://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs001286 The Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial is a large population-based randomized trial designed and sponsored by the National Cancer Institute (NCI) to determine the effects of screening on cancer-related mortality and secondary endpoints in over 150,000 men and women aged 55 to 74. The screening component of the trial was completed in 2006. However, participants have been under follow-up for cancer incidence and mortality since that time. In addition, PLCO included a large biological sample biorepository which has served as a unique resource for cancer research, particularly for etiologic and early-marker studies. As part of these efforts, PLCO has been used for a large number of genome-wide association and exome sequencing studies for different types of cancer.
Länk
Nyckelord
Versioner (1)
- 2023-03-20 2023-03-20 - Simon Heim
Rättsinnehavare
Neal Freedman, PhD, MPH, National Cancer Institute, Rockville, MD, USA
Uppladdad den
20 mars 2023
DOI
För en begäran logga in.
Licens
Creative Commons BY 4.0
Modellkommentarer :
Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.
Itemgroup-kommentar för :
Item-kommentar för :
Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.
dbGaP phs001286 The Prostate, Lung, Colon, Ovary Screening Trial (PLCO)
Sample ID, histological type of sample, body site where sample was obtained, analyte type, tumor status of sample, and array platform of participants with or without prostate, lung, colon, and ovary cancer and involved in the "The Prostate, Lung, Colon, Ovary Screening Trial (PLCO)" project.
- StudyEvent: SEV1
- Eligibility Criteria
- Subject ID, consent group, and sex of participants with or without prostate, lung, colon, and ovary cancer and involved in the "The Prostate, Lung, Colon, Ovary Screening Trial (PLCO)" project.
- Subject ID and sample ID sex of participants with or without prostate, lung, colon, and ovary cancer and involved in the "The Prostate, Lung, Colon, Ovary Screening Trial (PLCO)" project.
- Subject ID and sex of participants with or without prostate, lung, colon, and ovary cancer and involved in the "The Prostate, Lung, Colon, Ovary Screening Trial (PLCO)" project.
- Sample ID, histological type of sample, body site where sample was obtained, analyte type, tumor status of sample, and array platform of participants with or without prostate, lung, colon, and ovary cancer and involved in the "The Prostate, Lung, Colon, Ovary Screening Trial (PLCO)" project.
Similar models
Sample ID, histological type of sample, body site where sample was obtained, analyte type, tumor status of sample, and array platform of participants with or without prostate, lung, colon, and ovary cancer and involved in the "The Prostate, Lung, Colon, Ovary Screening Trial (PLCO)" project.
- StudyEvent: SEV1
- Eligibility Criteria
- Subject ID, consent group, and sex of participants with or without prostate, lung, colon, and ovary cancer and involved in the "The Prostate, Lung, Colon, Ovary Screening Trial (PLCO)" project.
- Subject ID and sample ID sex of participants with or without prostate, lung, colon, and ovary cancer and involved in the "The Prostate, Lung, Colon, Ovary Screening Trial (PLCO)" project.
- Subject ID and sex of participants with or without prostate, lung, colon, and ovary cancer and involved in the "The Prostate, Lung, Colon, Ovary Screening Trial (PLCO)" project.
- Sample ID, histological type of sample, body site where sample was obtained, analyte type, tumor status of sample, and array platform of participants with or without prostate, lung, colon, and ovary cancer and involved in the "The Prostate, Lung, Colon, Ovary Screening Trial (PLCO)" project.
C1299222 (UMLS CUI [1,2])
C1608383 (UMLS CUI [1,2])
C5419552 (UMLS CUI [1,3])
C2936475 (UMLS CUI [1,4])
C0014792 (UMLS CUI [1,5])
C5401001 (UMLS CUI [1,2])
C0226896 (UMLS CUI [1,3])
C1710360 (UMLS CUI [1,2])
C4687476 (UMLS CUI [1,3])